Schedule an Appointment
Directions
International
Billing
Sign Into MyChart
Ways to Help
Donate Now
Patients and Family
Patients and Family Home
Schedule an Appointment
Services and Specialties
Find a Doctor
Visiting Cincinnati Children's
Health Library
Additional Resources
Coronavirus Resources
Clinical Trials/Research Studies
Patient Resources
Vaccine Resources
Special Needs Resources
Healthcare Professionals
Healthcare Professionals Home
Services and Specialties
Clinical Trials
Find a Doctor
Refer a Patient
Additional Resources
Coronavirus Resources
Browse Careers
Patient Resources
Provider Resources
Continuing Professional Education
Clinical Training Programs
Graduate Medical Education
Clinical Laboratories
Nursing
Researchers
Research Home
Find a Researcher
Research Areas
Education and Training
Additional Resources
Shared Core Facilities
Research Support Services
Research Foundation
Funded Training
Browse Careers
Search
I want to
Find a Researcher
View Research Areas
Explore Research Training
View Shared Core Facilities
View Support Services
Read Research News
Read the Research Annual Report
View Clinical Trials
Browse Careers
Make a Donation
Schedule an Appointment
Directions
International
Billing
Sign Into MyChart
Ways to Help
Donate Now
Popular search terms
Coronavirus
Careers
Urgent Care
MyChart
Neurology
Volunteer
Bone Marrow Transplantation and Immune Deficiency
Home
Researchers
Research Foundation
Annual Reports
2017 Research Annual Report
Reports
Bone Marrow Transplantation and Immune Deficiency
Publications
Navigate
Close
Bone Marrow Transplantation and Immune Deficiency
Featured Research
Publications
Grants
Selected Publications
Top 25 Publications from FY17 Based on Impact Factor
Rotz SJ; Dandoy CE; Davies SM.
ST2 and Endothelial Injury as a Link between GVHD and Microangiopathy.
The New England journal of medicine
. 2017; 376:1189-1190.
de la Morena MT; Leonard D; Torgerson TR; Cabral-Marques O; Slatter M; Aghamohammadi A; Chandra S; Murguia-Favela L; Bonilla FA; Kanariou M.
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
Journal of Allergy and Clinical Immunology
. 2017; 139:1282-1292.
Chandrakasan S; Marsh RA; Uzel G; Holland SM; Shah KN; Bleesing J.
Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.
Journal of Allergy and Clinical Immunology
. 2017; 139:1040-1043.e2.
Rubin TS; Zhang K; Gifford C; Lane A; Choo S; Bleesing JJ; Marsh RA.
Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.
Blood
. 2017; 129:2993-2999.
Lounder DT; Khandelwal P; Dandoy CE; Jodele S; Grimley MS; Wallace G; Lane A; Taggart C; Teusink-Cross AC; Lake KE.
Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children.
Blood
. 2017; 129:2801-2807.
Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L.
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Blood
. 2017; 129:2308-2315.
Holtan SG; Khera N; Levine JE; Chai X; Storer B; Liu HD; Inamoto Y; Chen GL; Mayer S; Arora M.
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.
Blood
. 2016; 128:2350-2358.
Khoury HJ; Wang T; Hemmer MT; Couriel D; Alousi A; Cutler C; Aljurf M; Battiwalla M; Cahn JY; Cairo M.
Improved survival after acute graft-versus-host disease diagnosis in the modern era.
Haematologica: the hematology journal
. 2017; 102:958-966.
Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H.
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
Haematologica: the hematology journal
. 2016; 101:1267-1274.
Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES.
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience
. 2017; 37:3776-3788.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM.
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
Cancer
. 2017; 123:1828-1838.
Dandoy CE; Hausfeld J; Flesch L; Hawkins D; Demmel K; Best D; Osterkamp E; Bracke T; Nagarajan R; Jodele S.
Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.
BMJ Quality and Safety
. 2016; 25:633-643.
Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW.
Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
The Journal of biological chemistry
. 2017; 292:9666-9679.
Rebecca AM.
Diagnostic dilemmas in HLH: Can T-cell phenotyping help?.
European Journal of Immunology
. 2017; 47:240-243.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J.
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Biology of Blood and Marrow Transplantation
. 2017; 23:726-735.
Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA.
Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
Biology of Blood and Marrow Transplantation
. 2017; 23:857-860.
Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y.
Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
Biology of Blood and Marrow Transplantation
. 2017; 23:820-829.
Marsh RA; Fukuda T; Emoto C; Neumeier L; Khandelwal P; Chandra S; Teusink-Cross A; Vinks AA; Mehta PA.
Pretransplant Absolute Lymphocyte Counts Impact the Pharmacokinetics of Alemtuzumab.
Biology of Blood and Marrow Transplantation
. 2017; 23:635-641.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK.
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Biology of Blood and Marrow Transplantation
. 2017; 23:512-521.
Khandelwal P; Emoto C; Fukuda T; Vinks AA; Neumeier L; Dandoy CE; El-Bietar J; Chandra S; Davies SM; Bleesing JJ.
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
Biology of Blood and Marrow Transplantation
. 2016; 22:2220-2225.
Khandelwal P; Bleesing JJ; Davies SM; Marsh RA.
A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
Biology of Blood and Marrow Transplantation
. 2016; 22:2011-2018.
Teusink-Cross A; Davies SM; Danziger-Isakov L; El-Bietar J; Grimley MS.
Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients.
Biology of Blood and Marrow Transplantation
. 2016; 22:1904-1906.
Khandelwal P; Fukuda T; Mizuno K; Teusink-Cross A; Mehta PA; Marsh RA; Kashuba ADM; Vinks AA; Davies SM.
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses.
Biology of Blood and Marrow Transplantation
. 2016; 22:1829-1835.
Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S.
Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
Biology of Blood and Marrow Transplantation
. 2016; 22:1671-1677.
Ballen K; Woo Ahn K; Chen M; Abdel-Azim H; Ahmed I; Aljurf M; Antin J; Bhatt AS; Boeckh M; Chen G.
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
Biology of Blood and Marrow Transplantation
. 2016; 22:1636-1645.